• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Advances in evaluation and management of hair loss disorders.

作者信息

Valdebran Manuel

机构信息

Department of Dermatology, Medical University of South Carolina, Charleston, SC, United States.

Department of Pediatrics, Medical University of South Carolina, Charleston, SC, United States.

出版信息

Front Med (Lausanne). 2023 Jan 20;10:1131286. doi: 10.3389/fmed.2023.1131286. eCollection 2023.

DOI:10.3389/fmed.2023.1131286
PMID:36744146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9895931/
Abstract
摘要

相似文献

1
Editorial: Advances in evaluation and management of hair loss disorders.社论：脱发疾病评估与管理的进展
Front Med (Lausanne). 2023 Jan 20;10:1131286. doi: 10.3389/fmed.2023.1131286. eCollection 2023.
2
Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors.斑秃：病例报告及对发病机制和使用JAK抑制剂治疗的综述
J Autoimmun. 2022 Dec;133:102926. doi: 10.1016/j.jaut.2022.102926. Epub 2022 Nov 3.
3
Oral tofacitinib for the treatment of alopecia areata in pediatric patients.口腔托法替尼治疗儿童斑秃。
Pediatr Dermatol. 2022 Jan;39(1):31-34. doi: 10.1111/pde.14855. Epub 2021 Nov 14.
4
Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.Janus 激酶抑制剂治疗严重斑秃：一项开放性比较研究。
Dermatology. 2019;235(2):130-136. doi: 10.1159/000494613. Epub 2018 Dec 19.
5
Systematic review - alopecia areata and tofacitinib in paediatric patients.系统评价 - 斑秃和托法替尼在儿科患者中的应用。
Cutan Ocul Toxicol. 2022 Jun;41(2):194-201. doi: 10.1080/15569527.2022.2084622. Epub 2022 Jun 10.
6
Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review.托法替布作为斑秃的一种实用治疗选择：一项回顾性研究。
Dermatol Ther. 2022 Apr;35(4):e15310. doi: 10.1111/dth.15310. Epub 2022 Jan 17.
7
Tofacitinib Treatment in Patients With Active COVID-19 Infection.托法替布治疗活动性新型冠状病毒肺炎感染患者
Cureus. 2021 Sep 14;13(9):e17957. doi: 10.7759/cureus.17957. eCollection 2021 Sep.
8
Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?病例报告：托法替尼治疗普秃成功及细胞因子水平升高：正常治疗反应还是危险信号？
Front Immunol. 2022 Jun 20;13:904156. doi: 10.3389/fimmu.2022.904156. eCollection 2022.
9
Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata.局部用SCD - 153，一种衣康酸4 - 甲酯前药，用于治疗斑秃。
PNAS Nexus. 2022 Dec 16;2(1):pgac297. doi: 10.1093/pnasnexus/pgac297. eCollection 2023 Jan.
10
[JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].用于治疗斑秃的JAK抑制剂
Harefuah. 2020 Jan;159(1):38-42.

本文引用的文献

1
Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata.美国青少年斑秃患者的医疗服务利用情况及费用
J Health Econ Outcomes Res. 2022 Jul 29;9(2):11-18. doi: 10.36469/001c.36229. eCollection 2022.
2
Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels.斑秃在全球、区域和国家各级的流行病学趋势。
Front Immunol. 2022 Jul 14;13:874677. doi: 10.3389/fimmu.2022.874677. eCollection 2022.
3
Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study.口服托法替布与全身性皮质类固醇单独或联合用于中度至重度斑秃患者的回顾性研究
Front Med (Lausanne). 2022 Jun 21;9:891434. doi: 10.3389/fmed.2022.891434. eCollection 2022.
4
Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study.斑秃患者的疾病负担：一项横断面在线调查研究。
J Investig Dermatol Symp Proc. 2020 Nov;20(1):S62-S68. doi: 10.1016/j.jisp.2020.05.007.
5
Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.斑秃、全秃和普秃的流行病学：系统回顾和荟萃分析。
J Am Acad Dermatol. 2020 Mar;82(3):675-682. doi: 10.1016/j.jaad.2019.08.032. Epub 2019 Aug 19.
6
Association of Out-of-Pocket Health Care Costs and Financial Burden for Patients With Alopecia Areata.斑秃患者自付医疗费用与经济负担的关联。
JAMA Dermatol. 2019 Apr 1;155(4):493-494. doi: 10.1001/jamadermatol.2018.5218.
7
Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.斑秃：疾病特征、临床评估及发病机制的新观点。
J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141.
8
Objective outcome measures: Collecting meaningful data on alopecia areata.客观结果测量：收集斑秃有意义的数据。
J Am Acad Dermatol. 2018 Sep;79(3):470-478.e3. doi: 10.1016/j.jaad.2017.10.048. Epub 2017 Nov 8.
9
Alopecia Areata: An Update on Treatment Options for Children.斑秃：儿童治疗选择的最新进展
Paediatr Drugs. 2017 Oct;19(5):411-422. doi: 10.1007/s40272-017-0239-z.
10
Epidemiology and burden of alopecia areata: a systematic review.斑秃的流行病学与负担：一项系统综述
Clin Cosmet Investig Dermatol. 2015 Jul 24;8:397-403. doi: 10.2147/CCID.S53985. eCollection 2015.